Lovastatin 40mg (30)
Lovastatin Tablet
Product Images NDC 83209-143
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 83209-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boswell Pharmacy Services Llc D/b/a Bps Wholesale, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula (Lov00 0004 01)
Table I (Lov00 0004 02)
Figure 1 (Lov00 0004 03)
This text provides information on the proportion of participants without acute major coronary events over a specific period of follow-up, as indicated in Figure 1. It appears to focus on the primary endpoint of the study related to acute major coronary events occurring over time.*
Table Vii (Lov00 0005 04)
This text provides a table categorizing drug interactions associated with an increased risk of myopathy/rhabdomyolysis. It lists specific drugs and classes of drugs, along with prescribing recommendations to manage the risks. The recommendations include avoiding certain drugs with lovastatin, not exceeding specific daily doses of lovastatin when used with other drugs, and avoiding grapefruit juice consumption. The table mentions interacting agents like strong CYP3A4 inhibitors, HIV protease inhibitors, and certain medications like Cyclosporine, Danazol, Diltiazem, and Dronedarone.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
